Certara Inc

Research Certara Inc (CERT) on Bullrun: market cap USD 1.24B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 1.24B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 418.84M-USD 1.60MUSD 94.57M61.5%-0.01USD 189.39MUSD 293.09MUSD 1.06B
FY2024USD 385.15M-USD 12.05MUSD 78.84M59.9%-0.08USD 179.18MUSD 295.43MUSD 1.06B
FY2023USD 354.34M-USD 55.36MUSD 80.98M60.2%-0.35USD 234.95MUSD 291.24MUSD 1.05B
FY2022USD 335.64MUSD 14.73MUSD 91.11M60.5%0.09USD 236.59MUSD 293.01MUSD 1.08B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 1.24Bn/an/an/a
20252025-12-31USD 1.40Bn/an/an/a
20242024-12-31USD 1.71Bn/an/an/a
20232023-12-29USD 2.81Bn/an/an/a
20222022-12-30USD 2.57Bn/an/an/a
20212021-12-31USD 4.54Bn/an/an/a

About Certara Inc

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Certara Inc's market cap?

Certara Inc's market capitalization is USD 1.24B.

What does Certara Inc do?

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.